Project Grant R01GM143626
- The National Cancer Institute (NCI) awarded a $400,000 Project Grant under CFDA 93.394 (Cancer Detection and Diagnosis Research) to O2M Technologies LLC to develop a Multifunctional Imager (MFI) that can simultaneously acquire tissue oxygen pressure (pO2) and pH maps using electron paramagnetic resonance imaging (EPRI) techniques. The 12-month project aims to create a 25 MT Halbach-type permanent magnet, new multi-modal transmit-receive electronics, and the integrated MFI instrument. This...
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,835,840 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to purchase a clinical-grade NVISION POLARIS C13 Polarizer. This instrument enables hyperpolarization of C13 substrates, providing over a 10,000-fold increase in MRI signal for metabolic imaging. The award will allow Massachusetts General Hospital to be the only...
- This Project Grant award for $298,000, provided by the National Science Foundation (NSF) Division of Chemistry under the Mathematical and Physical Sciences (CFDA 47.049) program, supports collaborative research between professors at Southern Illinois University Carbondale and Wayne State University. The project aims to improve the sensitivity of nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) through the development of new, cost-effective means of enhancing nuclear...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $305,000 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to Odmr Technologies, Inc. to develop a miniature diamond quantum sensor for magnetoencephalography (MEG). The key objectives are to: 1) Build a miniature flux-concentrator diamond sensor with infrared absorption detection, and 2) Demonstrate a sensitivity of ~10 femtotesla for 1 second...
- The National Science Foundation (NSF) Directorate for Engineering awarded a $150,000 Project Grant to the University of Alabama in Huntsville (UAH) to support the development of new magnetic particle imaging tracers. The goal is to create superparamagnetic iron oxide nanoparticle clusters with controlled properties that can be used to improve magnetic particle imaging, a non-invasive medical imaging technique similar to MRI. Key objectives include designing and synthesizing poly(amino acid)...
- The National Science Foundation Division of Chemistry awarded a $899,956 Project Grant to the Research Foundation of the City University of New York to support research under the Mathematical and Physical Sciences program (CFDA 47.049). The funding will support Professor Meriles at the City College of New York in developing new nanoscale sensing and imaging techniques leveraging the physical properties of select light emitters in diamond. Specifically, the grant aims to enhance the information...
- This $128,740 National Science Foundation (NSF) Project Grant award to Brown University, funded through the NSF Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (CFDA 47.041 - Engineering), is supporting collaborative research to develop new magnetic particle imaging (MPI) tracer platforms. The key objectives are to create controlled clustering of superparamagnetic iron oxide nanoparticles using specialized polymers derived from natural amino acids, in order to...
- HYQ Research Solutions, LLC was awarded a $998,104 Cooperative Agreement from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program to develop high dielectric constant materials for accelerating 1.5T magnetic resonance imaging. The two-year award will support the company's efforts to increase MRI signal-to-noise ratio by over 50% and cut scan times in half through incorporating high dielectric constant materials into clinical imaging coils. This novel...
- This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an innovative magnetic resonance imaging (MRI) technology. The $391,875 award to The General Hospital Corporation, doing business as Massachusetts General Hospital, aims to address the flip angle inhomogeneity issue in high-field 7...
- This Project Grant award of $212,408 from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) supports research by Duke University to develop nitrogen-15 (15N)-labeled probes for monitoring glutamine metabolism using hyperpolarized magnetic resonance spectroscopy and imaging (MRS/MRI). The research aims to create new tools for sensitive and specific detection of metabolic steps...
PHOTO-HYPERPOLARIZED 13C MRI - SUMMARY. HIGH RESOLUTION IMAGING IN DEEP TISSUE (> 1 CM) ENVIRONMENTS CAN ADDRESS A SWATHE OF FUNDA- MENTAL AND APPLIED PROBLEMS IN THE ELUCIDATION OF MECHANISMS OF DISEASE ORIGIN AND PROGRESSION. WHILE FLUORES- CENCE IMAGING IS A WORKHORSE TECHNIQUE FOR THE CELLULAR IMAGING OF BIOLOGICAL MOLECULAR MARKERS, IT SUFFERS FROM LIGHT SCATTERING, AND ABERRATION DISTORTIONS AT TISSUE DEPTHS >1 MM. ON THE OPPOSITE END OF THE SPECTRUM, MAG- NETIC RESONANCE IMAGING (MRI) IS A WELL-ESTABLISHED AND BROADLY EMPLOYED PRE-CLINICAL AND CLINICAL IMAGING METHOD THAT HAS NO PRACTICAL LIMITATIONS WITH RESPECT TO TISSUE DEPTH, BUT IT SUFFERS FROM LOW RESOLUTION. IN THIS PROJECT WE WILL INNOVATE A NEW CLASS OF HYPERPOLARIZED 13C NANOPARTICLE PROBES THAT CAN SERVE AS EFFICIENT DEEP TISSUE MARKERS IN MRI. OUR CENTRAL IDEA IS TO DRAMATICALLY BOOST 13C NMR SIGNAL BY MEANS OF (I) OPTICAL HYPERPO- LARIZATION THAT CAN BE CARRIED OUT AT LOW MAGNETIC FIELDS AND (II) SIGNIFICANT EXTENSION OF 13C COHERENCE TIMES. SPECIFICALLY, WE PROPOSE TO DEVELOP MRI PROBES BASED ON FLUORESCENT NANODIAMONDS (FNDS) ENDOWED WITH NITROGEN-VACANCY (NV) CENTERS. THE ELECTRONIC SPINS ASSOCIATED WITH NVS CAN BE OPTICALLY "HYPERPOLARIZED" AND THAT POLARIZATION TO BE EFFECTIVELY TRANSFERRED TO THE DIAMOND 13C NUCLEAR SPINS, RESULTING IN NMR SIGNAL ENHANCE- MENT OVER THREE ORDERS OF MAGNITUDE VS. 13C THERMAL POLARIZATION AT THE FIELDS OF CLINICAL MRI. IN CONJUNCTION, BY IMPLEMENTING EFFECTIVE DECOUPLING SCHEMES WE PROPOSE SIGNIFICANTLY EXTEND THE 13C SPIN COHERENCES TO BE ABLE TO INTERROGATE THEM FOR SECOND-LONG PERIODS. THE LATTER YIELDS ENORMOUS SIGNAL GAINS, A MULTIPLICATIVE FACTOR OF ANOTHER 103- FOLD. COMBINING THE GAINS DUE TO HYPERPOLARIZATION AND SPIN COHERENCE EXTENSIONS PERMITS A TOTAL SIGNAL GAIN OF CA. 106 FOR MRI, AND WILL ENABLE A SIGNIFICANT IMPROVEMENT IN SPATIAL RESOLUTION. MOREOVER, SINCE THE POLARIZATION IS OPTICALLY GENERATED, THIS 13C PHOTO-MRI (PMRI), CAN BE CARRIED OUT AT LOW-FIELD AT A MUCH LOWER COST VS. CONVENTIONAL MRI INFRASTRUCTURE. IN OUR METHOD THE SPIN POLARIZATION IS REGENERATED OPTICALLY, ALLOWING FOR ACQUIRING MRI DATA REPEATEDLY AND ENABLING LONGITUDINAL STUDIES. FURTHERMORE, THE FND PARTICLES ARE INHERENTLY BIOCOMPATIBLE, AND THEIR SURFACES ARE AMENABLE TO A VERSATILE SET OF TARGETING LIGANDS. WITH THIS BASIS, WE PROPOSE TO DEVELOP TARGETABLE FLUORESCENT NANOPARTICLE MRI PROBES THAT CAN BE IMAGED WITH HIGH FIDELITY WITH RESOLUTION BETTER THAN 20 UM IN DEEP TISSUE (>1 CM) SETTINGS. IN ADDITION TO BEING BRIGHT MRI AGENTS, THE PARTICLES ARE ALSO BRIGHT FLUORESCENT PROVIDING AN OPTION FOR A CROSS-EXAMINATION OF THE AGENT BIODISTRIBUTION IN HISTOPATHOLOGICAL ANALYSIS. IN ORDER TO REALIZE THE PROSPECTS OF THIS NOVEL TECHNOLOGY, WE PROPOSE TO FURTHER DEVELOP THE HYPERPO- LARIZATION AND MR IMAGING METHODOLOGIES, AS WELL AS BOOST HYPERPOLARIZABILITY OF NANOSIZED PARTICLES BY OPTIMIZ- ING THEIR STRUCTURE THROUGH SYNTHESIS AND PROCESSING DEVELOPMENTS. WE AIM AT TRANSFERRING THE PMRI TECHNOLOGY WE DEMONSTRATED FOR MICRON-SIZED PARTICLES TO THE NANOSIZED FND SUITABLE FOR IN VIVO MRI. AS A PART OF THE TECHNOLOGY DEMONSTRATION, WE WILL CONSTRUCT A SIMPLE PROTOTYPE PMRI IMAGING SET-UP ON THE BENCHTOP (LOW-FIELD) AND IMAGE FNDS IN TISSUE PHANTOMS, CHARACTERIZING ACHIEVABLE METRICS OF RESOLUTION AND IMAGING DEPTH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $332.8k | 9/19/25 | ||
| Not listed | $0 | 9/16/25 | ||
| Not listed | $333.8k | 9/17/24 | ||
| Not listed | $337.2k | 9/6/23 | ||
| Not listed | $0 | 4/25/23 |